CoChat

Statistical Analysis of Cost‐effectiveness Data

Willan, Andrew R., Briggs, Andrew H. · 2006 · Wiley eBooks

The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index; none of the 1 sources its claims cite is checked for support yet.

Abstract

Preface. 1. Concepts. 1.1 Introduction. 1.2 Cost-effectiveness data and the parameters of interest. 1.3 The cost-effectiveness plane, the ICER and INB. 1.4 Outline. 2. Parameter Estimation for Non-censored Data. 2.1 Introduction. 2.2 Cost. 2.3 Effectiveness. 2.4 Summary. 3. Parameter Estimation for Censored Data. 3.1 Introduction. 3.2 Mean Cost. 3.3 Effectiveness. 3.4 Summary. 4. Cost-effectiveness Analysis. 4.1 Introduction. 4.2 Incremental cost-effectiveness ratio. 4.3 Incremental net benefit. 4.4 The cost-effectiveness acceptability curve. 4.5 Using bootstrap methods. 4.6 A Bayesian incremental net benefit approach. 4.7 Kinked thresholds. 4.8 Summary. 5. Cost-effectiveness Analysis: Examples. 5.1 Introduction. 5.2 The CADET-Hp trial. 5.3 Symptomatic hormone-resistant prostate cancer. 5.4 The Canadian implantable defibrillator study (CIDS). 5.5 The EVALUATE trial. 5.6 Bayesian approach applied to the UK PDS study. 5.7 Summary. 6. Power and Sample Size Determination. 6.1 Introduction. 6.2 Approaches based on the cost-effectiveness plane. 6.3 The classical approach based on net benefit. 6.4 Bayesian take on the classical approach. 6.5 The value of information approach. 6.6 Summary. 7. Covariate Adjustment and Sub-group Analysis. 7.1 Introduction. 7.2 Non-censored data. 7.3 Censored data. 7.4 Summary. 8. Multicenter and Multinational Trials. 8.1 Introduction. 8.2 Background to multinational cost-effectiveness. 8.3 Fixed effect approaches. 8.4 Random effects approaches. 8.5 Summary. 9. Modeling Cost-effectiveness. 9.1 Introduction. 9.2 A general framework for modeling cost-effectiveness results. 9.3 Case study: an economic appraisal of the goal study. 9.4 Summary. References. Author Index. Subject Index. Series List.

Overview

CoChat Summary

TL;DR

Willan and Briggs’s book is described as a thorough, authoritative guide to the statistical analysis of cost and effectiveness data collected alongside clinical trials. It covers core estimation, confidence intervals, skewed and censored data, then moves to power/sample size, covariate adjustment, multinational trials, and indirect estimation of ICER.

Key findings

  • The book has 9 chapters; the first five are described as the core, giving a self-contained treatment of basic CEA concepts and methods for estimating the mean, variance, and covariance of costs and effectiveness, plus the mean incremental cost-effectiveness ratio (ICER) and mean incremental net benefits (INB) and their confidence intervals.
  • The core chapters also address skewed and censored data and include several worked examples illustrating the methods developed.
  • The remaining chapters cover more specialized issues including power and sample size determination, using baseline covariates to adjust for confounding, multilevel and multinational trials, and statistical modeling for indirectly estimating ICER.
  • The reviewer says the book is “thorough and authoritative,” “well written and very useful,” and an “immensely valuable up-to-date guide” for the literature on CEA data analysis.

Methods

  • This is a book review, not an empirical study.
  • The text reviewed is a 9-chapter book focused on statistical methods for cost and effectiveness data collected alongside clinical trials.
  • The review summarizes the book’s treatment of estimation, confidence intervals, skewed/censored data, power/sample size, covariate adjustment, multinational trials, and indirect ICER estimation.

Limitations

  • The authors “could have made their book more readable” and broadened its audience by changing the style of presentation and including other topics.
  • The review says the book is not exhaustive for a growing field; it does not cover probabilistic sensitivity analysis of cost-effectiveness models and omits some issues such as specification and measurement errors, heteroscedasticity, and autocorrelation.
  • Evident from the review: the treatment is specialized, and the book is aimed mainly at readers with interest or background in CEA/statistics rather than a general audience.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1002/0470856289

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 Valid · 2 Not valid · 1 Not checked · 6 Own results and interpretations

4 more claims

Create a free account to see all 9 claims and to verify the 1 reference still open.

See all claims — free account

Citations

Cites

Research works printed but not linked: 3

  1. Barlow, R., Bartholomew, D., Bremner, J., and Brunk, H. (1972), Statistical Inference Under Order Restrictions , New York: Wiley.
  2. Robertson, T., Wright, F. T., and Dykstra, R. (1988), Order-Restricted Statistical Inference , New York: Wiley.
  3. Silvapulle, M., and Sen, P. K. (2004), Constrained Statistical Inference , New York: Wiley.

Cited by

See all 158

Metadata

Authors
Willan, A. R., & Briggs, A. H.
Venue
Wiley eBooks
Publisher
Wiley
Published
2006-07-14
OpenAlex
W376156748
Cited by
155
References
53
Citations by year
2021: 11 · 2020: 7 · 2019: 8 · 2018: 6 · 2017: 10 · 2016: 6 · 2015: 8 · 2014: 14 · 2013: 8 · 2012: 16
FWCI
18.19
Type
book
Language
en
Open access
closed
Licence
doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
Locations
Wiley eBooks (publishedVersion)
Topics
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
  • Physical Sciences › Mathematics › Statistics and Probability › Advanced Causal Inference Techniques
Keywords
cost-effectiveness analysis, incremental cost-effectiveness ratio, incremental net benefit, cost-effectiveness acceptability curves, censored data, bootstrapping, value of information, sample size and power, covariate adjustment, subgroup analysis, random effects models, economic evaluation, health technology assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-09-24 (prompt extract-v1).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.